Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diloxanide Furoate + Metronidazole for Amoebic Liver Abscess
NCT07807150Phase 3Not yet recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 3 trial of diloxanide in amoebic liver abscess (ALA), sponsored by Post Graduate Institute of Medical Education and Research. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
diloxanide
03
Conditions
amoebic liver abscess (ALA)
Beyond the preview
Go deeper on NCT07807150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807150.